Balchem Corporation

Founded in 1967, Balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Our Company consists of four business segments: Human Nutrition & Health; Specialty Products; Animal Nutrition and Health and Industrial Products. Balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions.
Company Growth (employees)
Type
Public
HQ
New Hampton, US
Founded
1967
Size (employees)
1,060 (est)
Balchem Corporation was founded in 1967 and is headquartered in New Hampton, US

Key People/Management at Balchem Corporation

Ted Harris

Ted Harris

Chairman and Chief Executive Officer
Mark Stach

Mark Stach

General Counsel
William Backus

William Backus

Chief Accounting Officer and Treasurer
Mike Size

Mike Size

Vice President/General Manager Ingredient Solutions
Jim Hyde

Jim Hyde

Vice President/General Manager Human Nutrition and Pharma
Ria Dake

Ria Dake

General Manager Cereal Systems
Jonathan Griffin

Jonathan Griffin

Vice President/General Manager Animal Nutrition and Health
David Ludwig

David Ludwig

Vice President/General Manager Specialty and Industrial Products
Scott Mason

Scott Mason

Vice President, Manufacturing and Supply Chain
Michael Sestrick

Michael Sestrick

Chief Technology Officer
Brent Tignor

Brent Tignor

Vice President, Human Resources
Jeff McCartney

Jeff McCartney

Director of Information Technology
Terry Coelho

Terry Coelho

Chief Financial Officer

Balchem Corporation Office Locations

Balchem Corporation has offices in New Hampton, Reading, Seattle, Covington and in 6 other locations
New Hampton, US (HQ)
52 Sunrise Park Rd
Show all (10)

Balchem Corporation Financials and Metrics

Balchem Corporation Financials

Balchem Corporation's revenue was reported to be $553.2 m in FY, 2016
USD

Revenue (Q2, 2017)

147.1 m

Gross profit (Q2, 2017)

46.8 m

Gross profit margin (Q2, 2017), %

32%

Net income (Q2, 2017)

16.5 m

Market capitalization (22-Dec-2017)

2.6 b

Cash (30-Jun-2017)

43.6 m

EV

2.8 b
Balchem Corporation's current market capitalization is $2.6 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

337.2 m541.4 m552.5 m553.2 m

Revenue growth, %

61%2%0%

Cost of goods sold

239.8 m397.2 m384.4 m372.3 m

Gross profit

97.4 m144.2 m168.1 m180.9 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

87.6 m86 m132.2 m160.5 m144.9 m134.8 m140.1 m135.1 m138.8 m138.5 m137.7 m147.1 m

Cost of goods sold

63.1 m62.8 m99.9 m116 m101.7 m92.9 m97 m92.3 m92.3 m93.9 m93.3 m100.3 m

Gross profit

24.5 m23.2 m32.3 m44.5 m43.1 m41.9 m43.2 m42.8 m46.4 m44.7 m44.4 m46.8 m

Gross profit Margin, %

28%27%24%28%30%31%31%32%33%32%32%32%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

208.7 m50.3 m84.8 m38.6 m

Inventories

24.8 m49.6 m46.1 m57.2 m

Current Assets

277.8 m181.3 m198.8 m188.4 m

PP&E

54.9 m131.6 m158.5 m165.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

190.2 m207.3 m59.7 m25.4 m56.6 m72.2 m81.6 m39.2 m33.4 m32.5 m37 m43.6 m

Accounts Receivable

40.5 m

Inventories

24.7 m24.9 m57 m58.2 m50.5 m47.9 m50.7 m60.4 m57.8 m56.7 m62.9 m62.1 m

Current Assets

258.5 m284.9 m199.3 m163.8 m179.1 m193.5 m204.1 m177.5 m169 m172.8 m187 m201.8 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

44.9 m52.8 m59.7 m56 m

Depreciation and Amortization

10.5 m30.5 m40 m46.2 m

Accounts Receivable

3 m(8.4 m)10.8 m(15.7 m)

Inventories

(3.9 m)6.7 m3.1 m4.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

11.7 m8.9 m9.7 m15.2 m15.2 m30.1 m44.1 m11.9 m26 m40 m15.5 m32.1 m

Depreciation and Amortization

19.9 m29.8 m11 m22.7 m34.4 m11.3 m22.1 m

Accounts Receivable

8 m7.3 m(1 m)1.1 m(522 k)4.1 m1.9 m

Inventories

57 m58.2 m50.5 m1.4 m(1.4 m)1.3 m4 m5.5 m(5.6 m)(2 m)
Y, 2017

EV/CFO

60.8 x

EV/FCF

79.7 x

Financial Leverage

1.7 x
Show all financial metrics

Balchem Corporation Operating Metrics

Balchem Corporation's Backlog was reported to be 26.2 m in FY, 2016, which is a 14% decrease from the previous period
FY, 2015FY, 2016

Backlog

30.45 m26.2 m

Facilities

19

Patents Issued

109
Show all operating metrics

Balchem Corporation Market Value History

Balchem Corporation Revenue Breakdown

Balchem Corporation's Web-traffic and Trends

Balchem Corporation Online and Social Media Presence

Balchem Corporation Company Life and Culture

You may also be interested in